Publicaciones en colaboración con investigadores/as de Hospital de Cabueñes (23)

2023

  1. BTLA dysregulation correlates with poor outcome and diminished T cell-mediated antitumor responses in chronic lymphocytic leukemia

    Cancer Immunology, Immunotherapy, Vol. 72, Núm. 7, pp. 2529-2539

  2. Randomized phase II study of weekly carfilzomib 70 mg/m2 and dexamethasone with or without cyclophosphamide in relapsed and/or refractory multiple myeloma patients

    Haematologica, Vol. 108, Núm. 10, pp. 2753-2763

2022

  1. Prognostic Value of Serum Paraprotein Response Kinetics in Patients With Newly Diagnosed Multiple Myeloma

    Clinical Lymphoma, Myeloma and Leukemia, Vol. 22, Núm. 9, pp. e844-e852

  2. RICORS2040: The need for collaborative research in chronic kidney disease

    Clinical Kidney Journal, Vol. 15, Núm. 3, pp. 372-387

2021

  1. A new and short protocol to achieve the early diagnosis of mild cognitive impairment

    Neurological Sciences, Vol. 42, Núm. 9, pp. 3687-3694

  2. Btla/hvem axis induces nk cell immunosuppression and poor outcome in chronic lymphocytic leukemia

    Cancers, Vol. 13, Núm. 8

  3. Lag‐3 blockade with relatlimab (Bms‐986016) restores anti‐leukemic responses in chronic lymphocytic leukemia

    Cancers, Vol. 13, Núm. 9

  4. Unfolded p53 as a Marker of Oxidative Stress in Mild Cognitive Impairment, Alzheimer's and Parkinson's Disease

    Current Alzheimer research, Vol. 18, Núm. 9, pp. 695-700

2020

  1. Competitive electrochemical immunosensor for the detection of unfolded p53 protein in blood as biomarker for Alzheimer's disease

    Analytica Chimica Acta, Vol. 1093, pp. 28-34

  2. Platelet-derived bio-products: Classification update, applications, concerns and new perspectives

    Transfusion and Apheresis Science, Vol. 59, Núm. 1

2019

  1. Bortezomib, lenalidomide, and dexamethasone as induction therapy prior to autologous transplant in multiple myeloma

    Blood, Vol. 134, Núm. 16, pp. 1337-1345

  2. The Mithralog EC-7072 Induces Chronic Lymphocytic Leukemia Cell Death by Targeting Tonic B-Cell Receptor Signaling

    Frontiers in Immunology, Vol. 10

2018

  1. Ig-Like Transcript 2 (ILT2) Blockade and Lenalidomide Restore NK Cell Function in Chronic Lymphocytic Leukemia

    Frontiers in immunology, Vol. 9, pp. 2917

2016

  1. Bortezomib plus CHOP for the treatment of HIV-associated plasmablastic lymphoma: Clinical experience in three patients

    Leukemia and Lymphoma

2015

  1. On the prediction of Hodgkin lymphoma treatment response

    Clinical and Translational Oncology, Vol. 17, Núm. 8, pp. 612-619

  2. Serum ferritin as prognostic marker in classical Hodgkin lymphoma treated with ABVD-based therapy

    Leukemia and Lymphoma, Vol. 56, Núm. 11, pp. 3096-3102

2014

  1. Expansion of NK cells and reduction of NKG2D expression in chronic lymphocytic leukemia.Correlation with progressive disease

    PLoS ONE, Vol. 9, Núm. 10

  2. Lymphomatoid granulomatosis of central nervous system and lung driven by Epstein Barr virus proliferation: Successful treatment with rituximab-containing chemotherapy

    Mediterranean Journal of Hematology and Infectious Diseases, Vol. 6, Núm. 1

2013

  1. Lenalidomide and chronic lymphocytic leukemia

    BioMed Research International, Vol. 2013

2012

  1. Expression of ERp5 and GRP78 on the membrane of chronic lymphocytic leukemia cells: Association with soluble MICA shedding

    Cancer Immunology, Immunotherapy, Vol. 61, Núm. 8, pp. 1201-1210